Analystreport

Akero Therapeutics, Inc. (NASDAQ: AKRO) had its price target raised by analysts at Raymond James from $14.00 to $25.00.

Akero Therapeutics, Inc.  (AKRO) 
Last akero therapeutics, inc. earnings: 3/16 07:30 am Check Earnings Report